CH646966A5 - Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung. - Google Patents

Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung. Download PDF

Info

Publication number
CH646966A5
CH646966A5 CH215381A CH215381A CH646966A5 CH 646966 A5 CH646966 A5 CH 646966A5 CH 215381 A CH215381 A CH 215381A CH 215381 A CH215381 A CH 215381A CH 646966 A5 CH646966 A5 CH 646966A5
Authority
CH
Switzerland
Prior art keywords
group
hydrogen atom
butyryl
carbon atoms
straight
Prior art date
Application number
CH215381A
Other languages
German (de)
English (en)
Inventor
Aiya Sato
Akira Terahara
Yoshio Tsujita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12604367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH646966(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of CH646966A5 publication Critical patent/CH646966A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH215381A 1980-03-31 1981-03-30 Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung. CH646966A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55041292A JPH0692381B2 (ja) 1980-03-31 1980-03-31 Ｍｂ−５３０ａ誘導体

Publications (1)

Publication Number Publication Date
CH646966A5 true CH646966A5 (de) 1984-12-28

Family

ID=12604367

Family Applications (1)

Application Number Title Priority Date Filing Date
CH215381A CH646966A5 (de) 1980-03-31 1981-03-30 Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung.

Country Status (15)

Country Link
JP (1) JPH0692381B2 (enrdf_load_html_response)
AT (1) ATA150781A (enrdf_load_html_response)
AU (1) AU6893281A (enrdf_load_html_response)
BE (1) BE888214A (enrdf_load_html_response)
CH (1) CH646966A5 (enrdf_load_html_response)
DE (2) DE3112566A1 (enrdf_load_html_response)
DK (3) DK151273C (enrdf_load_html_response)
FI (1) FI810991L (enrdf_load_html_response)
FR (1) FR2479222A1 (enrdf_load_html_response)
GB (1) GB2073193A (enrdf_load_html_response)
IE (1) IE52367B1 (enrdf_load_html_response)
IT (1) IT1144325B (enrdf_load_html_response)
MX (1) MX9203567A (enrdf_load_html_response)
NL (1) NL8101592A (enrdf_load_html_response)
SE (1) SE461590B (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472426A (en) * 1982-12-22 1984-09-18 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3682557D1 (de) * 1985-09-13 1992-01-02 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US5075327A (en) * 1988-08-10 1991-12-24 Hoffmann-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5021451A (en) * 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
FR2937537A1 (fr) 2008-10-29 2010-04-30 Centre Nat Rech Scient Nanoparticules de statine
KR101820099B1 (ko) 2013-01-18 2018-01-18 에스프린팅솔루션 주식회사 저항 발열체, 이를 채용한 가열 부재, 및 정착 장치
JP2021509907A (ja) * 2018-01-09 2021-04-08 リガンド・ファーマシューティカルズ・インコーポレイテッド アセタール化合物およびその治療的使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (enrdf_load_html_response) * 1974-06-07 1981-03-18
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンｋおよびその製造法
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
ZA81703B (en) * 1980-02-04 1982-09-29 Merck & Co Inc New antihypercholesterolemic compounds,intermediates and processes
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds

Also Published As

Publication number Publication date
DE3153666C2 (de) 1993-11-11
AU6893281A (en) 1981-10-08
JPH0692381B2 (ja) 1994-11-16
DK32190D0 (da) 1990-02-07
DE3112566C2 (enrdf_load_html_response) 1990-04-05
DK32290D0 (da) 1990-02-07
DK151273C (da) 1988-07-04
SE8102047L (sv) 1981-10-01
BE888214A (fr) 1981-09-30
IE810698L (en) 1981-09-30
DK167805B1 (da) 1993-12-20
SE461590B (sv) 1990-03-05
DE3112566A1 (de) 1982-03-11
IE52367B1 (en) 1987-09-30
NL8101592A (nl) 1981-10-16
FR2479222B1 (enrdf_load_html_response) 1983-08-26
IT8167438A0 (it) 1981-03-30
FI810991A7 (fi) 1981-10-01
JPS56138181A (en) 1981-10-28
DK145481A (da) 1981-10-01
IT1144325B (it) 1986-10-29
MX9203567A (es) 1992-09-01
DK32190A (da) 1990-02-07
DK151273B (da) 1987-11-16
GB2073193A (en) 1981-10-14
FI810991L (fi) 1981-10-01
FR2479222A1 (fr) 1981-10-02
ATA150781A (de) 1983-03-15
DK32290A (da) 1990-02-07

Similar Documents

Publication Publication Date Title
DE60120685T2 (de) Verfahren zur herstellung von dihydroxyestern und ihren derivaten
CH645890A5 (de) Monacolin k, seine herstellung und dieses enthaltendes antihypercholesterinaemisches mittel.
DE69832987T2 (de) Spingosinanaloga
CH645891A5 (de) Verfahren zur herstellung von monacolin k.
DD157344A5 (de) Verfahren zur herstellung von polyhydro-3,7-dimethyl-8-2-(tetrahydro-4-hydroxy-6-oxo-2h-pyran-2-yl)-aethyl-1-napthtylenyl-2-methylbutanoaten und deren entsprechenden saeuren
CH646966A5 (de) Die cholesterinbiosynthese hemmende verbindungen, ihre herstellung und verwendung.
DE4320023A1 (de) Holotyp-Stamm Aspergillus obscurus und Verfahren zur Herstellung von µ,£-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{methyl}-butyryloxy)-naphthalin-1-yl]-heptansäure-£-lacton{Mevinolin} und/oder µ,5-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{mehtyl}-butyryloxy)-naphthalin-1-yl]-heptansäure
DE3028284A1 (de) Monacolin k-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
CH640270A5 (de) Verfahren zur herstellung des antibiotikums c-15003 p-3.
DE3114242A1 (de) Carbonsaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE69908569T2 (de) Verfahren zur herstellung von fexofenadin
DE2150593C2 (de) Neues Antibiotikum Ws-4545(Bicyclomycin), Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitung
DE2528984C3 (de) Bestatin, dessen Verwendung und Verfahren zu dessen Herstellung
DE2303495C2 (de) Herstellung von Ergosterin und seinen Estern
DD202047A5 (de) Verfahren zur herstellung des makrolids 20-dihydro-20,23-dideoxytylonolid
DE3247175A1 (de) Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel
KR840001958B1 (ko) 콜레스테롤 생합성 억제제의 제조방법
CH640269A5 (de) Verfahren zur herstellung des antibiotikums c-15003 p-4.
DE2014277A1 (de) Verfahren zur Herstellung von Acylderivaten des Antibiotikums T-2636 C
CH647790A5 (de) Makrolidantibiotika.
DE3224019C1 (de) Verfahren zur Herstellung von ß-(S)-Aminoglutarsäuremonoalkylestern
DE2921052C2 (enrdf_load_html_response)
AT381710B (de) Verfahren zur herstellung eines neuen macrolid-antibiotikums
DE2425582B2 (de) Verfahren zur herstellung von hydroxycyclopentenonderivaten
CH630879A5 (de) Verfahren zur herstellung lipidsenkender alkylenglykolderivate.

Legal Events

Date Code Title Description
PL Patent ceased